127 | 0 | 30 |
下载次数 | 被引频次 | 阅读次数 |
总结凃晋文教授运用补虚解毒通络法治疗颅内动脉粥样硬化性狭窄(ICAS)的临证经验。认为毒损脑络是ICAS的核心病机,提出以补虚解毒通络为核心治法。脑络空虚为发病之源,脾肾亏虚、元气不足者,方选四君子汤合六味地黄丸加减,健脾补肾以充络;浊瘀毒结是病机之要,浊瘀相合、蕴毒结络者,方选桃红四物汤合二陈汤加减,解毒散结以畅络;阴毒伏络是病邪之渐,浊瘀寒化、阴毒伏络者,方选补阳还五汤合涤痰汤加减,搜剔温补以活络;热毒损络是疾病之变,浊瘀热化、毒损脑络者,方选大柴胡汤合黄连解毒汤加减,凉血通腑以清络。
Abstract:This article summarized Professor TU Jinwen's experience in treatment of intracranial atherosclerotic stenosis(ICAS) with principles of supplementing deficiency, resolving toxins and unblocking Collaterals. He believes that toxin damaging brain collaterals is the core pathogenesis of ICAS, and thereafter proposed supplementing deficiency, resolving toxins, and unblocking collaterals be the basic treatment method. The emptiness of brain collaterals is the source of the disease. For cases where there is spleen kidney depletion and insufficiency of original qi, the modified Sijunzi Decoction and Liuwei Dihuang Pills(四君子汤合六味地黄丸) could be used to fortify the spleen and tonify the kidneys to enrich the collaterals. The accumulation of turbidity stasis toxin in brain collaterals is essential components of the pathogenesis. For cases where turbidity and stasis combine together, inducing toxins and obstructing the collaterals, the modified Taohong Siwu Decoction and Erchen Decoction(桃红四物汤合二陈汤) could be used to eliminate toxins and dispel knots to unblock the collaterals. Yin toxins obstructing the latent collaterals represent the gradual progression of pathogenic factors. For cases where turbid stasis transform into cold and yin toxins hide in the collaterals, the modified Buyang Huanwu Decoction and Ditan Decoction(补阳还五汤合涤痰汤) could be used to remove the toxin, warm and activate the collaterals. Heat toxins damaging the collaterals signify aggravated changes in disease. For cases where turbid stasis transforms into heat and toxins injure the brain collaterals, the modified Dachaihu Decoction and Huanglian Jiedu Decoction(大柴胡汤合黄连解毒汤) could be used to cool blood and dredge the fu viscera to clear collaterals.
[1]CHEN LH, SPAGNOLO-ALLENDE A, YANG D, et al.Epidemiology, pathophysiology, and imaging of atherosclerotic intracranial disease[J]. Stroke,2024,55(2):311-323.
[2]GUTIERREZ J, TURAN TN, HOH BL, et al. Intracranial atherosclerotic stenosis:risk factors, diagnosis, and treatment[J]. Lancet Neurol, 2022, 21(4):355-368.
[3]WININGER KL. Percutaneous transluminal coronary angioplasty:history,current techniques,and future directions[J]. Radiol Technol, 2022, 94(1):35-45.
[4]陈馨浓,葛其卉,赵一璇,等.从“脉中积”认识动脉粥样硬化[J].中医杂志,2022,63(16):1532-1537.
[5]张艳,杨关林,于睿,等.动脉粥样硬化中医虚瘀痰毒病因病机实质研究探讨[J].时珍国医国药,2007,18(6):1513-1514.
[6]栾玉洁,袁晨露,陈子真,等.基于积证理论运用攻、消、补、散法分期干预动脉粥样硬化的思路[J].中医杂志,2025,66(7):685-689.
[7]孙建慧,杨倩,刘阳,等.构建中医浊毒理论体系框架的思考[J].中医杂志,2020,61(8):660-663.
[8]祝海梅,龙云,程丑夫.从斑块寒热病性探讨冠心病病机及证治[J].中西医结合心脑血管病杂志,2024,22(13):2491-2493.
[9]杨化冰,邹小娟,高清华,等.代谢性炎症与动脉粥样硬化内生热毒病机探讨[J].湖北中医药大学学报,2019,21(1):48-51.
[10]李红梅,王婧文,孙晓婷,等.络风内动与动脉粥样硬化斑块内血管新生[J].中医杂志,2017,58(17):1462-1465,1472.
[11]胥怡帆,唐爱华,冯晓桃.基于瘀毒理论与血管平滑肌细胞表型转换的关系探讨动脉粥样硬化易损斑块的病机[J].中医学报,2024,39(11):2294-2298.
[12]张婧如,李姝凝,温韫然,等.痰瘀同治法治疗动脉粥样硬化研究进展[J].中国中医基础医学杂志,2025,31(1):157-161.
[13]陈丽云.严世芸运用膏方经验[J].中医杂志,2018,59(13):1099-1101.
基本信息:
DOI:10.13288/j.11-2166/r.2025.15.003
中图分类号:R249;R277.7
引用信息:
[1]陈一飞,陈小敏,丁砚兵等.凃晋文运用补虚解毒通络法治疗颅内动脉粥样硬化性狭窄经验[J].中医杂志,2025,66(15):1528-1533.DOI:10.13288/j.11-2166/r.2025.15.003.
基金信息:
湖北省中医药重点学科建设项目(鄂中医通[2023]2号); 国家中医药管理局第四届国医大师传承工作室建设项目(国中医药办人教函[2022]245号)